The formulations for which prices have been revised consist of a range of deriphyline formulation used for treatment of Asthma, Levodopa tablets for anti-Parkinson disease, Rubraplex liquid and Lederplex liquid used for vitamin deficiency and Ledermycin tablets used as broad spectrum antibiotics.

The prices have been fixed in accordance with the provision of the drugs prices control order.